GLP-1 medications linked to fewer deaths and amputations in people with type 2 diabetes and PAD. According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist (GLP-1 RA) medications reduce the number of deaths, amputations and hospitalizations among people with type 2 diabetes who also have narrowed leg arteries associated with PAD (peripheral artery disease).
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist (GLP-1 RA) medications reduce the number of deaths, amputations and hospitalizations among people with type 2 diabetes who also have narrowed leg arteries associated with PAD (peripheral artery disease).
- Ponto de atenção: medications.
- Ponto de atenção: linked.
- Ponto de atenção: fewer.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
:quality(85)/d179474a-2f12-4be1-826d-b37e5bd62bd9.png)